Sanofi's 3rd-qtr earning and sales miss expectations

French pharma major Sanofi (Euronext: SAN) today posted third-quarter 2017 financials, which came in slightly below expectations and showing that total sales rose 4.7% to 9.05 billion euros ($10.54 billion).

Business net income declined 1.1% (at constant exchange rates) to 2.141 billion euros. Earnings per share increased 1.1% at constant currencies, to 1.71 euros, but fell 4.5% at reported rates.

Analysts polled by Reuters were expecting business net profit of 2.148 billion euros and net sales of 9.33 billion euros. Sanofi’s shares dipped 1.76% to 79.11 euros in early trading,